BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11109636)

  • 1. [Decision aides in immunohematology: detection of anti-erythrocyte antibodies].
    Roubinet F; Mannessier L; Chiaroni J; Lauroua P
    Transfus Clin Biol; 2000 Oct; 7(5):513-8. PubMed ID: 11109636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Problem-solving in immunohematology: direct compatibility laboratory test ].
    Mannessier L; Roubinet F; Chiaroni J
    Transfus Clin Biol; 2001 Dec; 8(6):481-4. PubMed ID: 11802611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of feto-maternal red cell allo-immunizations].
    Bricca P; Guinchard E; Guitton Bliem C
    Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The field of erythrocyte immunohematology].
    Rouger P
    Transfus Clin Biol; 2000 Jun; 7 Suppl 1():36s-39s. PubMed ID: 10919222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Problem-solving in immunohematology: interpretation of ABO typing and its difficulties].
    Chiaroni J; Lauroua P; Roubinet F; Mannessier L
    Transfus Clin Biol; 2000 Feb; 7(1):84-95. PubMed ID: 10730350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3 new antibody detection tests. A comparative study].
    Mempel W; Alraun K; Leeping M; Kirschner M; Reiser H; Heim MU
    Beitr Infusionsther; 1990; 26():362-6. PubMed ID: 1703872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohematology.
    Virella G; Spivey MA
    Immunol Ser; 1993; 58():361-78. PubMed ID: 8424983
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-KANNO: a novel alloantibody against a red cell antigen of high frequency.
    Kawabata K; Uchikawa M; Ohto H; Yasuda H; Tsuneyama H; Tsuchida H; Ito S
    Transfus Med Rev; 2014 Jan; 28(1):23-8. PubMed ID: 24485899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemolytic disease of the newborn and irregular blood group antibodies in the Netherlands: prevalence and morbidity].
    van Dijk BA; Hirasing RA; Overbeeke MA
    Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1465-9. PubMed ID: 10443262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunohematologic study and transfusion approach to patients with public antibodies].
    Solves P; de la Rubia J; Arriaga F; Cervera J; Arnao M; Carpio N; Marty ML
    Sangre (Barc); 1997 Feb; 42(1):25-9. PubMed ID: 9229799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of antibodies in acid eluates with the gel microcolumn assay.
    Greco VA; Byrne KM; Procter JL; Stroncek DF
    Transfusion; 2002 Jun; 42(6):698-701. PubMed ID: 12147021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of anti-K-mediated hemolytic disease of newborns after the introduction of a matched transfusion policy: A nation-wide policy change evaluation study in the Netherlands.
    Luken JS; Folman CC; Lukens MV; Meekers JH; Ligthart PC; Schonewille H; Zwaginga JJ; Janssen MP; van der Schoot CE; van der Bom JG; de Haas M
    Transfusion; 2021 Mar; 61(3):713-721. PubMed ID: 33528025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E; Cavelier B; Bonneau JC; Rouger P
    Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of irregular antibodies in the department of transfusion medicine 1984-1988].
    Wittkopf D; Grundmann A; Sibrowski W; von Eisenhart-Rothe V; Kühnl P
    Beitr Infusionsther; 1990; 26():415-9. PubMed ID: 1703889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International forums--an Australian perspective.
    Ford DS
    Vox Sang; 1996; 70(4):239-40. PubMed ID: 9123934
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of the polyethyleneglycol antiglobulin test in the detection and identification of erythrocyte antibodies].
    Jiménez Marco MT; Hernández Maraver D; Rodríguez de la Rua A; de la Cámara Mendizábal C; Canales Albendea M; Jiménez Yuste V; Hernández Navarro F
    Sangre (Barc); 1998 Feb; 43(1):21-4. PubMed ID: 9577178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the clinical significance of blood group alloantibodies that are causing problems in pretransfusion testing.
    Garratty G
    Vox Sang; 1998; 74 Suppl 2():285-90. PubMed ID: 9704458
    [No Abstract]   [Full Text] [Related]  

  • 18. [Specificity and incidence of erythrocyte antibodies in pregnant patients with intrauterine transfusions for fetal erythroblastosis].
    Hoch H; Giers G; Bald R; Hanfland P
    Beitr Infusionsther; 1992; 30():439-42. PubMed ID: 1284755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do we need to be more concerned about weak D antigens?
    Garratty G
    Transfusion; 2005 Oct; 45(10):1547-51. PubMed ID: 16181202
    [No Abstract]   [Full Text] [Related]  

  • 20. It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group.
    Sandler SG; Flegel WA; Westhoff CM; Denomme GA; Delaney M; Keller MA; Johnson ST; Katz L; Queenan JT; Vassallo RR; Simon CD;
    Transfusion; 2015 Mar; 55(3):680-9. PubMed ID: 25438646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.